Reduced Size Self-Delivering Rnai Compounds (2013)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2011/029824, filed Mar 24, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,240,149 | Reduced Size Self-Delivering Rnai Compounds In force · High confidence | Phio Pharmaceuticals Corp. | In force | High confidence | ||
| US 11,118,178 | Reduced Size Self-Delivering Rnai Compounds In force · High confidence | Phio Pharmaceuticals Corp. | In force | High confidence | ||
| US 9,080,171 | Reduced Size Self-Delivering Rnai Compounds In force · High confidence | Phio Pharmaceuticals Corp. | In force | High confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.